Skip to main content
. 2019 Aug 6;3:PO.18.00361. doi: 10.1200/PO.18.00361

FIG 3.

FIG 3.

Risk of distant recurrence as a function of EPclin score for different interaction strengths under different assumptions about overall relative chemotherapy benefit: (A) 30%, (B) 20%, and (C) 40%. The threshold between high (3.3 or greater) and low (less than 3.3) EPclin scores is shown by the dashed line.